JP MORGAN/CALL/BECTON DICKINSON AND CO./265/0.1/17.01.25 Stock

Warrant

DE000JL1KNV1

Market Closed - Börse Stuttgart 03:20:38 2024-05-31 EDT
1.01 EUR +18.82% Intraday chart for JP MORGAN/CALL/BECTON DICKINSON AND CO./265/0.1/17.01.25
Current month-35.67%
1 month-35.67%
Date Price Change
24-05-31 1.01 +18.82%
24-05-30 0.85 -12.37%
24-05-29 0.97 -14.16%
24-05-28 1.13 +9.71%
24-05-27 1.03 -12.71%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 03:20 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNV
ISINDE000JL1KNV1
Date issued 2023-04-05
Strike 265 $
Maturity 2025-01-17 (230 Days)
Parity 10 : 1
Emission price 2.68
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.92
Lowest since issue 0.85
Delta0.38x
Omega 6.291
Premium20.3x
Gearing16.51x
Moneyness 0.8754
Difference Strike 33.03 $
Difference Strike %+12.46%
Spread 0.15
Spread %10.95%
Theoretical value 1.295
Implied Volatility 32.81 %
Total Loss Probability 70.94 %
Intrinsic value 0.000000
Present value 1.295
Break even 279.05 €
Theta-0.04x
Vega0.06x
Rho0.04x

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus